Supplementary Material for: Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.3808179.v1
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
2.0K
Citations
12
h-index
14
i10-index
D. Von Hoff is an academic researcher from Translational Genomics Research Institute. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Pancreatic and Hepatic Oncology Research & Cancer therapeutics and mechanisms. The author has an h-index of 12, co-authored 31 publications.
https://doi.org/10.6084/m9.figshare.3808179.v1
https://doi.org/10.36401/jipo-25-20
Click to start Chat